Advances in anti-drug antibody detection: Miniaturized biosensor technologies and beyond

dc.contributor.authorUludağ Anıl, İnci
dc.contributor.authorKemal Sezgintürk, Mustafa Kemal
dc.date.accessioned2026-02-03T11:53:42Z
dc.date.available2026-02-03T11:53:42Z
dc.date.issued2025
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractThe emergence of anti-drug antibodies (ADAs) poses a significant challenge in biological therapeutics, undermining drug efficacy and patient safety. This review thoroughly assesses existing and novel analytical methods for ADA detection, highlighting their principles, strengths, and limitations. Conventional techniques like ELISA and ECL provide great sensitivity but may be inadequate for detecting low-affinity ADAs. On the other hand, surface plasmon resonance (SPR) offers advantages in detecting low-affinity anti-drug antibodies (ADAs) due to its real-time kinetic assessment. Recent advancements in label-free technologies, such as thin-film interferometry, electrolyte-gated organic field-effect transistors, and quartz crystal microbalance, show significant potential for rapid, sensitive, and real-time ADA monitoring. These advanced platforms enable accurate kinetic characterization and offer promise for point-of-care applications. Additionally, novel approaches address limitations of conventional immunoassays by simplifying workflows and reducing assay time. This review underscores the importance of ADA assessment for optimizing personalized therapeutic strategies and improving patient outcomes. © 2025
dc.identifier.doi10.1016/j.jpbao.2025.100092
dc.identifier.scopus2-s2.0-105017620815
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.1016/j.jpbao.2025.100092
dc.identifier.urihttps://hdl.handle.net/20.500.12428/34294
dc.identifier.volume6
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofJournal of Pharmaceutical and Biomedical Analysis Open
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20260130
dc.subjectAnti-drug antibodies
dc.subjectBiosensor
dc.subjectImmunogenicity
dc.subjectMonoclonal antibodies
dc.subjectNeutralizing antibodies
dc.titleAdvances in anti-drug antibody detection: Miniaturized biosensor technologies and beyond
dc.typeReview

Dosyalar